FDA advisory panel rejects drug-device combination to treat Type 2 diabetes

The vote essentially upheld the Food and Drug Administration’s earlier rulings, with some members calling for new clinical studies to address the safety and dosing concerns.

Related Keywords

San Francisco ,California ,United States ,Boston ,Massachusetts ,Oklahoma ,Kelly Close ,Brendan Everett ,Rita Kalyani ,Lisa Connery ,Johns Hopkins University School Of Medicine ,Drug Evaluation ,Boston Based Intarcia Therapeutics ,Close Connections ,Johns Hopkins University School , ,